🇺🇸 FDA
Patent

US 6380178

Cyclic regimens using cyclocarbamate and cyclic amide derivatives

expired A61KA61K31/40A61K31/445

Quick answer

US patent 6380178 (Cyclic regimens using cyclocarbamate and cyclic amide derivatives) held by Ligand Pharmaceuticals Incorporated expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/40, A61K31/445, A61K31/535, A61K31/56